APO Research
Talk to an analyst

APO RESEARCH · REPORT

Targeted NGS Amplicon Sequencing Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Targeted NGS Amplicon Sequencing Services Market Outlook and Growth Opportunities 2026

12 August 2026217 pages

Choose your research edition.

Industry ResearchTargeted NGS Amplicon Sequencing Services Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeted NGS Amplicon Sequencing Services Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Targeted NGS Amplicon Sequencing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeted NGS Amplicon Sequencing Services Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeted NGS Amplicon Sequencing Services Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Targeted NGS Amplicon Sequencing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Targeted NGS Amplicon Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Targeted NGS Amplicon Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Targeted NGS Amplicon Sequencing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Targeted NGS Amplicon Sequencing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Targeted NGS Amplicon Sequencing Services market include Novogene, BGI (BGI Genomics), Macrogen, Psomagen, SeqMatic, CD Genomics, AllGenetics, Charles River and Source BioScience, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Targeted NGS Amplicon Sequencing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Targeted NGS Amplicon Sequencing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Targeted NGS Amplicon Sequencing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Targeted NGS Amplicon Sequencing Services market.

Targeted NGS Amplicon Sequencing Services Segment by Company

Novogene

BGI (BGI Genomics)

Macrogen

Psomagen

SeqMatic

CD Genomics

AllGenetics

Charles River

Source BioScience

AGRF

Plasmidsaurus

Eurofins Scientific

Charles River Laboratories

ABM

Zymo Research

Paragon Genomics

Quintara Bio

HyLabs

MUGTC

SeqCoast Genomics

Shanghai Baiqu Biomedical Technology

Illumina

Guangzhou IGE Biotechnology

IDT

Azenta Life Sciences

Eurofins Genomics

Targeted NGS Amplicon Sequencing Services Segment by Type

Single-Gene Sequencing

Multi-Gene Panel Sequencing

Customized Region Sequencing

Targeted NGS Amplicon Sequencing Services Segment by Application

Clinical Molecular Diagnostics

Human Genetics & Population Research

Agricultural Biotechnology & Breeding

Industrial Biotechnology

Others

Targeted NGS Amplicon Sequencing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Targeted NGS Amplicon Sequencing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Targeted NGS Amplicon Sequencing Services key companies, revenue, market share, and recent developments.

3. To split the Targeted NGS Amplicon Sequencing Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Targeted NGS Amplicon Sequencing Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Targeted NGS Amplicon Sequencing Services significant trends, drivers, influence factors in global and regions.

6. To analyze Targeted NGS Amplicon Sequencing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted NGS Amplicon Sequencing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeted NGS Amplicon Sequencing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted NGS Amplicon Sequencing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Targeted NGS Amplicon Sequencing Services industry.

Chapter 3: Detailed analysis of Targeted NGS Amplicon Sequencing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Targeted NGS Amplicon Sequencing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Targeted NGS Amplicon Sequencing Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Targeted NGS Amplicon Sequencing Services Industry Trends Table 2. Targeted NGS Amplicon Sequencing Services Industry Drivers Table 3. Targeted NGS Amplicon Sequencing Services Industry Opportunities and Challenges Table 4. Targeted NGS Amplicon Sequencing Services Industry Restraints Table 5. Global Targeted NGS Amplicon Sequencing Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Targeted NGS Amplicon Sequencing Services Revenue Share by Company (2021-2026) Table 7. Global Targeted NGS Amplicon Sequencing Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Targeted NGS Amplicon Sequencing Services Key Company Manufacturing Base & Headquarters Table 9. Global Targeted NGS Amplicon Sequencing Services Company, Product Type & Application Table 10. Global Targeted NGS Amplicon Sequencing Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Targeted NGS Amplicon Sequencing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single-Gene Sequencing Table 15. Significant Companies of Multi-Gene Panel Sequencing Table 16. Significant Companies of Customized Region Sequencing Table 17. Global Targeted NGS Amplicon Sequencing Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Targeted NGS Amplicon Sequencing Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Targeted NGS Amplicon Sequencing Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Type (2021-2026) Table 21. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Clinical Molecular Diagnostics Table 23. Significant Companies of Human Genetics & Population Research Table 24. Significant Companies of Agricultural Biotechnology & Breeding Table 25. Significant Companies of Industrial Biotechnology Table 26. Significant Companies of Others Table 27. Global Targeted NGS Amplicon Sequencing Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Targeted NGS Amplicon Sequencing Services Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Targeted NGS Amplicon Sequencing Services Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Application (2021-2026) Table 31. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Application (2027-2032) Table 32. Global Targeted NGS Amplicon Sequencing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Targeted NGS Amplicon Sequencing Services Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Region (2021-2026) Table 35. Global Targeted NGS Amplicon Sequencing Services Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Region (2027-2032) Table 37. Global Targeted NGS Amplicon Sequencing Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Targeted NGS Amplicon Sequencing Services Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Targeted NGS Amplicon Sequencing Services Sales Value Market Share by Country (2021-2026) Table 40. Global Targeted NGS Amplicon Sequencing Services Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Targeted NGS Amplicon Sequencing Services Sales Value Market Share by Country (2027-2032) Table 42. Novogene Company Information Table 43. Novogene Business Overview Table 44. Novogene Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Novogene Targeted NGS Amplicon Sequencing Services Product Portfolio Table 46. Novogene Recent Development Table 47. BGI (BGI Genomics) Company Information Table 48. BGI (BGI Genomics) Business Overview Table 49. BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Product Portfolio Table 51. BGI (BGI Genomics) Recent Development Table 52. Macrogen Company Information Table 53. Macrogen Business Overview Table 54. Macrogen Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Macrogen Targeted NGS Amplicon Sequencing Services Product Portfolio Table 56. Macrogen Recent Development Table 57. Psomagen Company Information Table 58. Psomagen Business Overview Table 59. Psomagen Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Psomagen Targeted NGS Amplicon Sequencing Services Product Portfolio Table 61. Psomagen Recent Development Table 62. SeqMatic Company Information Table 63. SeqMatic Business Overview Table 64. SeqMatic Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. SeqMatic Targeted NGS Amplicon Sequencing Services Product Portfolio Table 66. SeqMatic Recent Development Table 67. CD Genomics Company Information Table 68. CD Genomics Business Overview Table 69. CD Genomics Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. CD Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 71. CD Genomics Recent Development Table 72. AllGenetics Company Information Table 73. AllGenetics Business Overview Table 74. AllGenetics Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. AllGenetics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 76. AllGenetics Recent Development Table 77. Charles River Company Information Table 78. Charles River Business Overview Table 79. Charles River Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Charles River Targeted NGS Amplicon Sequencing Services Product Portfolio Table 81. Charles River Recent Development Table 82. Source BioScience Company Information Table 83. Source BioScience Business Overview Table 84. Source BioScience Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Source BioScience Targeted NGS Amplicon Sequencing Services Product Portfolio Table 86. Source BioScience Recent Development Table 87. AGRF Company Information Table 88. AGRF Business Overview Table 89. AGRF Targeted NGS Amplicon Sequencing Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. AGRF Targeted NGS Amplicon Sequencing Services Product Portfolio Table 91. AGRF Recent Development Table 92. Plasmidsaurus Company Information Table 93. Plasmidsaurus Business Overview Table 94. Plasmidsaurus Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Plasmidsaurus Targeted NGS Amplicon Sequencing Services Product Portfolio Table 96. Plasmidsaurus Recent Development Table 97. Eurofins Scientific Company Information Table 98. Eurofins Scientific Business Overview Table 99. Eurofins Scientific Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Eurofins Scientific Targeted NGS Amplicon Sequencing Services Product Portfolio Table 101. Eurofins Scientific Recent Development Table 102. Charles River Laboratories Company Information Table 103. Charles River Laboratories Business Overview Table 104. Charles River Laboratories Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Charles River Laboratories Targeted NGS Amplicon Sequencing Services Product Portfolio Table 106. Charles River Laboratories Recent Development Table 107. ABM Company Information Table 108. ABM Business Overview Table 109. ABM Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. ABM Targeted NGS Amplicon Sequencing Services Product Portfolio Table 111. ABM Recent Development Table 112. Zymo Research Company Information Table 113. Zymo Research Business Overview Table 114. Zymo Research Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Zymo Research Targeted NGS Amplicon Sequencing Services Product Portfolio Table 116. Zymo Research Recent Development Table 117. Paragon Genomics Company Information Table 118. Paragon Genomics Business Overview Table 119. Paragon Genomics Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Paragon Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 121. Paragon Genomics Recent Development Table 122. Quintara Bio Company Information Table 123. Quintara Bio Business Overview Table 124. Quintara Bio Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Quintara Bio Targeted NGS Amplicon Sequencing Services Product Portfolio Table 126. Quintara Bio Recent Development Table 127. HyLabs Company Information Table 128. HyLabs Business Overview Table 129. HyLabs Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. HyLabs Targeted NGS Amplicon Sequencing Services Product Portfolio Table 131. HyLabs Recent Development Table 132. MUGTC Company Information Table 133. MUGTC Business Overview Table 134. MUGTC Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. MUGTC Targeted NGS Amplicon Sequencing Services Product Portfolio Table 136. MUGTC Recent Development Table 137. SeqCoast Genomics Company Information Table 138. SeqCoast Genomics Business Overview Table 139. SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 141. SeqCoast Genomics Recent Development Table 142. Shanghai Baiqu Biomedical Technology Company Information Table 143. Shanghai Baiqu Biomedical Technology Business Overview Table 144. Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Product Portfolio Table 146. Shanghai Baiqu Biomedical Technology Recent Development Table 147. Illumina Company Information Table 148. Illumina Business Overview Table 149. Illumina Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Illumina Targeted NGS Amplicon Sequencing Services Product Portfolio Table 151. Illumina Recent Development Table 152. Guangzhou IGE Biotechnology Company Information Table 153. Guangzhou IGE Biotechnology Business Overview Table 154. Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Product Portfolio Table 156. Guangzhou IGE Biotechnology Recent Development Table 157. IDT Company Information Table 158. IDT Business Overview Table 159. IDT Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. IDT Targeted NGS Amplicon Sequencing Services Product Portfolio Table 161. IDT Recent Development Table 162. Azenta Life Sciences Company Information Table 163. Azenta Life Sciences Business Overview Table 164. Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Product Portfolio Table 166. Azenta Life Sciences Recent Development Table 167. Eurofins Genomics Company Information Table 168. Eurofins Genomics Business Overview Table 169. Eurofins Genomics Targeted NGS Amplicon Sequencing Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Eurofins Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio Table 171. Eurofins Genomics Recent Development Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Targeted NGS Amplicon Sequencing Services Product Image Figure 2. Global Targeted NGS Amplicon Sequencing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Targeted NGS Amplicon Sequencing Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Targeted NGS Amplicon Sequencing Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single-Gene Sequencing Image Figure 8. Multi-Gene Panel Sequencing Image Figure 9. Customized Region Sequencing Image Figure 10. Global Targeted NGS Amplicon Sequencing Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Targeted NGS Amplicon Sequencing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Type (2021-2032) Figure 13. Clinical Molecular Diagnostics Image Figure 14. Human Genetics & Population Research Image Figure 15. Agricultural Biotechnology & Breeding Image Figure 16. Industrial Biotechnology Image Figure 17. Others Image Figure 18. Global Targeted NGS Amplicon Sequencing Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Targeted NGS Amplicon Sequencing Services Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Application (2021-2032) Figure 21. Global Targeted NGS Amplicon Sequencing Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 24. North America Targeted NGS Amplicon Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Targeted NGS Amplicon Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Targeted NGS Amplicon Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 30. South America Targeted NGS Amplicon Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Targeted NGS Amplicon Sequencing Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Gene Sequencing
  • Multi-Gene Panel Sequencing
  • Customized Region Sequencing
Applications
  • Clinical Molecular Diagnostics
  • Human Genetics & Population Research
  • Agricultural Biotechnology & Breeding
  • Industrial Biotechnology
  • Others
Companies covered
  • Novogene
  • BGI (BGI Genomics)
  • Macrogen
  • Psomagen
  • SeqMatic
  • CD Genomics
  • AllGenetics
  • Charles River
  • Source BioScience
  • AGRF
  • Plasmidsaurus
  • Eurofins Scientific
  • Charles River Laboratories
  • ABM
  • Zymo Research
  • Paragon Genomics
  • Quintara Bio
  • HyLabs
  • MUGTC
  • SeqCoast Genomics
  • Shanghai Baiqu Biomedical Technology
  • Illumina
  • Guangzhou IGE Biotechnology
  • IDT
  • Azenta Life Sciences
  • Eurofins Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Targeted NGS Amplicon Sequencing Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Targeted NGS Amplicon Sequencing Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Targeted NGS Amplicon Sequencing Services Market Dynamics
  1. 2.1 Targeted NGS Amplicon Sequencing Services Industry Trends
  2. 2.2 Targeted NGS Amplicon Sequencing Services Industry Drivers
  3. 2.3 Targeted NGS Amplicon Sequencing Services Industry Opportunities and Challenges
  4. 2.4 Targeted NGS Amplicon Sequencing Services Industry Restraints
3 Targeted NGS Amplicon Sequencing Services Market by Company
  1. 3.1 Global Targeted NGS Amplicon Sequencing Services Company Revenue Ranking in 2025
  2. 3.2 Global Targeted NGS Amplicon Sequencing Services Revenue by Company (2021-2026)
  3. 3.3 Global Targeted NGS Amplicon Sequencing Services Company Ranking (2024-2026)
  4. 3.4 Global Targeted NGS Amplicon Sequencing Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Targeted NGS Amplicon Sequencing Services Company Product Type and Application
  6. 3.6 Global Targeted NGS Amplicon Sequencing Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Targeted NGS Amplicon Sequencing Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Targeted NGS Amplicon Sequencing Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Targeted NGS Amplicon Sequencing Services Market by Type
  1. 4.1 Targeted NGS Amplicon Sequencing Services Type Introduction
  2. 4.1.1 Single-Gene Sequencing
  3. 4.1.2 Multi-Gene Panel Sequencing
  4. 4.1.3 Customized Region Sequencing
  5. 4.2 Global Targeted NGS Amplicon Sequencing Services Sales Value by Type
  6. 4.2.1 Global Targeted NGS Amplicon Sequencing Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Targeted NGS Amplicon Sequencing Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Type (2021-2032)
5 Targeted NGS Amplicon Sequencing Services Market by Application
  1. 5.1 Targeted NGS Amplicon Sequencing Services Application Introduction
  2. 5.1.1 Clinical Molecular Diagnostics
  3. 5.1.2 Human Genetics & Population Research
  4. 5.1.3 Agricultural Biotechnology & Breeding
  5. 5.1.4 Industrial Biotechnology
  6. 5.1.5 Others
  7. 5.2 Global Targeted NGS Amplicon Sequencing Services Sales Value by Application
  8. 5.2.1 Global Targeted NGS Amplicon Sequencing Services Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Targeted NGS Amplicon Sequencing Services Sales Value by Application (2021-2032)
  10. 5.2.3 Global Targeted NGS Amplicon Sequencing Services Sales Value Share by Application (2021-2032)
6 Targeted NGS Amplicon Sequencing Services Regional Value Analysis
  1. 6.1 Global Targeted NGS Amplicon Sequencing Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Targeted NGS Amplicon Sequencing Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Targeted NGS Amplicon Sequencing Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Targeted NGS Amplicon Sequencing Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032)
  7. 6.3.2 North America Targeted NGS Amplicon Sequencing Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032)
  10. 6.4.2 Europe Targeted NGS Amplicon Sequencing Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Targeted NGS Amplicon Sequencing Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032)
  16. 6.6.2 South America Targeted NGS Amplicon Sequencing Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Targeted NGS Amplicon Sequencing Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Targeted NGS Amplicon Sequencing Services Sales Value Share by Country, 2025 VS 2032
7 Targeted NGS Amplicon Sequencing Services Country-level Value Analysis
  1. 7.1 Global Targeted NGS Amplicon Sequencing Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Targeted NGS Amplicon Sequencing Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Targeted NGS Amplicon Sequencing Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Targeted NGS Amplicon Sequencing Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Targeted NGS Amplicon Sequencing Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Targeted NGS Amplicon Sequencing Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Targeted NGS Amplicon Sequencing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novogene
  2. 8.1.1 Novogene Company Information
  3. 8.1.2 Novogene Business Overview
  4. 8.1.3 Novogene Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novogene Targeted NGS Amplicon Sequencing Services Product Portfolio
  6. 8.1.5 Novogene Recent Developments
  7. 8.2 BGI (BGI Genomics)
  8. 8.2.1 BGI (BGI Genomics) Company Information
  9. 8.2.2 BGI (BGI Genomics) Business Overview
  10. 8.2.3 BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BGI (BGI Genomics) Targeted NGS Amplicon Sequencing Services Product Portfolio
  12. 8.2.5 BGI (BGI Genomics) Recent Developments
  13. 8.3 Macrogen
  14. 8.3.1 Macrogen Company Information
  15. 8.3.2 Macrogen Business Overview
  16. 8.3.3 Macrogen Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Macrogen Targeted NGS Amplicon Sequencing Services Product Portfolio
  18. 8.3.5 Macrogen Recent Developments
  19. 8.4 Psomagen
  20. 8.4.1 Psomagen Company Information
  21. 8.4.2 Psomagen Business Overview
  22. 8.4.3 Psomagen Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Psomagen Targeted NGS Amplicon Sequencing Services Product Portfolio
  24. 8.4.5 Psomagen Recent Developments
  25. 8.5 SeqMatic
  26. 8.5.1 SeqMatic Company Information
  27. 8.5.2 SeqMatic Business Overview
  28. 8.5.3 SeqMatic Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 SeqMatic Targeted NGS Amplicon Sequencing Services Product Portfolio
  30. 8.5.5 SeqMatic Recent Developments
  31. 8.6 CD Genomics
  32. 8.6.1 CD Genomics Company Information
  33. 8.6.2 CD Genomics Business Overview
  34. 8.6.3 CD Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CD Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
  36. 8.6.5 CD Genomics Recent Developments
  37. 8.7 AllGenetics
  38. 8.7.1 AllGenetics Company Information
  39. 8.7.2 AllGenetics Business Overview
  40. 8.7.3 AllGenetics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AllGenetics Targeted NGS Amplicon Sequencing Services Product Portfolio
  42. 8.7.5 AllGenetics Recent Developments
  43. 8.8 Charles River
  44. 8.8.1 Charles River Company Information
  45. 8.8.2 Charles River Business Overview
  46. 8.8.3 Charles River Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Charles River Targeted NGS Amplicon Sequencing Services Product Portfolio
  48. 8.8.5 Charles River Recent Developments
  49. 8.9 Source BioScience
  50. 8.9.1 Source BioScience Company Information
  51. 8.9.2 Source BioScience Business Overview
  52. 8.9.3 Source BioScience Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Source BioScience Targeted NGS Amplicon Sequencing Services Product Portfolio
  54. 8.9.5 Source BioScience Recent Developments
  55. 8.10 AGRF
  56. 8.10.1 AGRF Company Information
  57. 8.10.2 AGRF Business Overview
  58. 8.10.3 AGRF Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AGRF Targeted NGS Amplicon Sequencing Services Product Portfolio
  60. 8.10.5 AGRF Recent Developments
  61. 8.11 Plasmidsaurus
  62. 8.11.1 Plasmidsaurus Company Information
  63. 8.11.2 Plasmidsaurus Business Overview
  64. 8.11.3 Plasmidsaurus Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Plasmidsaurus Targeted NGS Amplicon Sequencing Services Product Portfolio
  66. 8.11.5 Plasmidsaurus Recent Developments
  67. 8.12 Eurofins Scientific
  68. 8.12.1 Eurofins Scientific Company Information
  69. 8.12.2 Eurofins Scientific Business Overview
  70. 8.12.3 Eurofins Scientific Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Eurofins Scientific Targeted NGS Amplicon Sequencing Services Product Portfolio
  72. 8.12.5 Eurofins Scientific Recent Developments
  73. 8.13 Charles River Laboratories
  74. 8.13.1 Charles River Laboratories Company Information
  75. 8.13.2 Charles River Laboratories Business Overview
  76. 8.13.3 Charles River Laboratories Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Charles River Laboratories Targeted NGS Amplicon Sequencing Services Product Portfolio
  78. 8.13.5 Charles River Laboratories Recent Developments
  79. 8.14 ABM
  80. 8.14.1 ABM Company Information
  81. 8.14.2 ABM Business Overview
  82. 8.14.3 ABM Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ABM Targeted NGS Amplicon Sequencing Services Product Portfolio
  84. 8.14.5 ABM Recent Developments
  85. 8.15 Zymo Research
  86. 8.15.1 Zymo Research Company Information
  87. 8.15.2 Zymo Research Business Overview
  88. 8.15.3 Zymo Research Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Zymo Research Targeted NGS Amplicon Sequencing Services Product Portfolio
  90. 8.15.5 Zymo Research Recent Developments
  91. 8.16 Paragon Genomics
  92. 8.16.1 Paragon Genomics Company Information
  93. 8.16.2 Paragon Genomics Business Overview
  94. 8.16.3 Paragon Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Paragon Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
  96. 8.16.5 Paragon Genomics Recent Developments
  97. 8.17 Quintara Bio
  98. 8.17.1 Quintara Bio Company Information
  99. 8.17.2 Quintara Bio Business Overview
  100. 8.17.3 Quintara Bio Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Quintara Bio Targeted NGS Amplicon Sequencing Services Product Portfolio
  102. 8.17.5 Quintara Bio Recent Developments
  103. 8.18 HyLabs
  104. 8.18.1 HyLabs Company Information
  105. 8.18.2 HyLabs Business Overview
  106. 8.18.3 HyLabs Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 HyLabs Targeted NGS Amplicon Sequencing Services Product Portfolio
  108. 8.18.5 HyLabs Recent Developments
  109. 8.19 MUGTC
  110. 8.19.1 MUGTC Company Information
  111. 8.19.2 MUGTC Business Overview
  112. 8.19.3 MUGTC Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 MUGTC Targeted NGS Amplicon Sequencing Services Product Portfolio
  114. 8.19.5 MUGTC Recent Developments
  115. 8.20 SeqCoast Genomics
  116. 8.20.1 SeqCoast Genomics Company Information
  117. 8.20.2 SeqCoast Genomics Business Overview
  118. 8.20.3 SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 SeqCoast Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
  120. 8.20.5 SeqCoast Genomics Recent Developments
  121. 8.21 Shanghai Baiqu Biomedical Technology
  122. 8.21.1 Shanghai Baiqu Biomedical Technology Company Information
  123. 8.21.2 Shanghai Baiqu Biomedical Technology Business Overview
  124. 8.21.3 Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Shanghai Baiqu Biomedical Technology Targeted NGS Amplicon Sequencing Services Product Portfolio
  126. 8.21.5 Shanghai Baiqu Biomedical Technology Recent Developments
  127. 8.22 Illumina
  128. 8.22.1 Illumina Company Information
  129. 8.22.2 Illumina Business Overview
  130. 8.22.3 Illumina Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Illumina Targeted NGS Amplicon Sequencing Services Product Portfolio
  132. 8.22.5 Illumina Recent Developments
  133. 8.23 Guangzhou IGE Biotechnology
  134. 8.23.1 Guangzhou IGE Biotechnology Company Information
  135. 8.23.2 Guangzhou IGE Biotechnology Business Overview
  136. 8.23.3 Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Guangzhou IGE Biotechnology Targeted NGS Amplicon Sequencing Services Product Portfolio
  138. 8.23.5 Guangzhou IGE Biotechnology Recent Developments
  139. 8.24 IDT
  140. 8.24.1 IDT Company Information
  141. 8.24.2 IDT Business Overview
  142. 8.24.3 IDT Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  143. 8.24.4 IDT Targeted NGS Amplicon Sequencing Services Product Portfolio
  144. 8.24.5 IDT Recent Developments
  145. 8.25 Azenta Life Sciences
  146. 8.25.1 Azenta Life Sciences Company Information
  147. 8.25.2 Azenta Life Sciences Business Overview
  148. 8.25.3 Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Azenta Life Sciences Targeted NGS Amplicon Sequencing Services Product Portfolio
  150. 8.25.5 Azenta Life Sciences Recent Developments
  151. 8.26 Eurofins Genomics
  152. 8.26.1 Eurofins Genomics Company Information
  153. 8.26.2 Eurofins Genomics Business Overview
  154. 8.26.3 Eurofins Genomics Targeted NGS Amplicon Sequencing Services Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Eurofins Genomics Targeted NGS Amplicon Sequencing Services Product Portfolio
  156. 8.26.5 Eurofins Genomics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst